Amedisys

AMED56

$90.29arrow_drop_down0.22%-$0.19

AMED56

$90.29

arrow_drop_down0.22%-$0.19

Performance History

Key Stats
Open	$90.77
Prev. Close	$90.49
EPS	2.48
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	90.22	92.86
52 Week Range	89.55	98.95

Ratios







EPS	2.48

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Amedisys (AMED)

Amedisys Inc. (AMED) is a leading healthcare company that provides home health and hospice care. With a strong focus on delivering high-quality care, the company has established itself as a trusted provider in the industry. Amedisys operates across the United States and serves over 400,000 patients annually. The company's mission is to enhance the lives of its patients by delivering compassionate, personalized care in the comfort of their own homes. Amedisys offers a comprehensive range of services, including nursing care, therapy services, and medical social work. The company's team of skilled professionals is dedicated to helping patients achieve their health goals and improve their quality of life.

Amedisys Inc. is focused on driving growth and innovation in the healthcare industry. The company is committed to investing in technology and research to improve patient outcomes and drive operational efficiency. Amedisys has a strong track record of delivering strong financial performance. In 2020, the company reported net service revenue of $2.3 billion, a 15% increase compared to the previous year. Amedisys' strong financial position allows it to continue investing in its growth initiatives and expand its presence in the market. The company's commitment to quality and patient satisfaction has been recognized by various industry organizations. Amedisys has received several accolades, including being named a HomeCare Elite Top Agency and a Fortune Future 50 company.

Websitecall_made

Sector: Healthcare
Industry: Medical Care Facilities
CEO: Mr. Richard M. Ashworth
Headquarters: Baton Rouge
Employees: 20000
Exchange: NASDAQ

Keep an eye on Amedisys

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Amedisys 's (AMED) price per share?

The current price per share for Amedisys (AMED) is $90.29. The stock has seen a price change of -$0.2 recently, indicating a -0.22% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Amedisys (AMED)?

For Amedisys (AMED), the 52-week high is $98.95, which is 9.59% from the current price. The 52-week low is $89.55, the current price is 0.83% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Amedisys (AMED) stock price performance year to date (YTD)?

As of the latest data, Amedisys (AMED) has a year-to-date price change of -4.93%. Over the past month, the stock has experienced a price change of -6.73%. Over the last three months, the change has been -7.92%. Over the past six months, the figure is -5.36%. Looking at a longer horizon, the five-year price change stands at -39.87%.

help

Is Amedisys (AMED) a growth stock?

Amedisys (AMED) has shown an average price growth of -3.55% over the past three years. It has received a score of 25 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Amedisys as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

Is Amedisys (AMED) a profitable company?

Amedisys (AMED) has a net income of -$9.75M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 20.44% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 8% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.24B, with a revenue growth rate of 0.59%, providing insight into the company's sales performance and growth. The gross profit is $457.08M. Operating income is noted at $156.39M. Furthermore, the EBITDA is $286.93M.

help

What is the market capitalization of Amedisys (AMED)?

Amedisys (AMED) has a market capitalization of $2.96B. The average daily trading volume is 90.34, indicating the stock's liquidity and investor engagement.